Microbix Biosystems (MBX) Competitors

Microbix Biosystems (TSE:MBX) and Theratechnologies (TSE:TH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

Does the media favor MBX or TH?

In the previous week, Microbix Biosystems and Microbix Biosystems both had 2 articles in the media. Microbix Biosystems' average media sentiment score of 0.58 beat Theratechnologies' score of 0.37 indicating that Microbix Biosystems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbix Biosystems	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Theratechnologies	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts recommend MBX or TH?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbix Biosystems	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Theratechnologies	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	3.00

Is MBX or TH more profitable?

Microbix Biosystems has a net margin of 13.86% compared to Theratechnologies' net margin of -3.75%. Theratechnologies' return on equity of 14.30% beat Microbix Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbix Biosystems	13.86%	12.65%	3.82%
Theratechnologies	-3.75%	14.30%	5.15%

Which has more volatility and risk, MBX or TH?

Microbix Biosystems has a beta of 0.34, meaning that its stock price is 66% less volatile than the S&P 500. Comparatively, Theratechnologies has a beta of 1.73, meaning that its stock price is 73% more volatile than the S&P 500.

Which has better earnings & valuation, MBX or TH?

Microbix Biosystems has higher earnings, but lower revenue than Theratechnologies. Theratechnologies is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbix Biosystems	C$24.42M	1.59	C$3.39M	C$0.03	11.24
Theratechnologies	C$52.22M	2.65	-C$1.96M	-C$0.09	-49.13

Do insiders and institutionals hold more shares of MBX or TH?

0.4% of Microbix Biosystems shares are held by institutional investors. Comparatively, 51.2% of Theratechnologies shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by insiders. Comparatively, 1.2% of Theratechnologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Theratechnologies beats Microbix Biosystems on 8 of the 14 factors compared between the two stocks.